COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosingCOPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosing

Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosing and treating certain types of cancers, announced that CEO Ulrich Krasilnikoff and CMO prof. Andreas Kjær will be in San Francisco during the 44th J.P. Morgan Healthcare Conference being held January 12-15, 2026.

During the week, Curasight management will hold meetings with investors and other industry stakeholders. The meetings will include updates on the Company’s clinical progress, including the recent initiation of a Phase 1 trial with uTREAT® in aggressive brain cancer, and the ongoing Phase 2 trial of uTRACE® in prostate cancer conducted in partnership with Curium Inc.

About the uPAR theranostic platform

Curasight’s uPAR theranostic platform combines two key technologies – uTRACE and uTREAT both targeting the uPAR receptor. uTRACE is designed to deliver sensitive imaging for diagnosis, while uTREAT offers a targeted radiopharmaceutical solution. Together, they form an integrated approach to improving the diagnosis and treatment of cancers that express uPAR. Curasight’s ambition is to develop both uTRACE and uTREAT to improve diagnosis and treatment of uPAR-expressing cancers.

For more information regarding Curasight, please contact:
Ulrich Krasilnikoff, CEO
Phone: +45 22 83 01 60
E-mail: uk@curasight.com

www.curasight.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/curasight/r/curasight-to-hold-meetings-in-san-francisco-during-j-p–morgan-healthcare-conference-week,c4288616

The following files are available for download:

https://mb.cision.com/Main/19744/4288616/3862590.pdf

Curasight Press release – JPM 26

Cision View original content:https://www.prnewswire.com/news-releases/curasight-to-hold-meetings-in-san-francisco-during-jp-morgan-healthcare-conference-week-302652512.html

SOURCE Curasight

Market Opportunity
PoP Planet Logo
PoP Planet Price(P)
$0.01549
$0.01549$0.01549
+0.32%
USD
PoP Planet (P) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

‘One Battle After Another’ Becomes One Of This Decade’s Best-Reviewed Movies

‘One Battle After Another’ Becomes One Of This Decade’s Best-Reviewed Movies

The post ‘One Battle After Another’ Becomes One Of This Decade’s Best-Reviewed Movies appeared on BitcoinEthereumNews.com. Topline Critics have hailed Paul Thomas Anderson’s “One Battle After Another,” starring Leonardo DiCaprio, as a “masterpiece,” indicating potential Academy Awards success as it boasts near-perfect scores on review aggregators Metacritic and Rotten Tomatoes based on early reviews. Leonardo DiCaprio stars in “One Battle After Another,” which opens in theaters next week. (Photo by Jeff Spicer/Getty Images for Warner Bros. Pictures) Getty Images for Warner Bros. Pictures Key Facts “One Battle After Another” boasts a nearly perfect 97 out of a possible 100 on Metacritic based on its first 31 reviews, making it the highest-rated movie of this decade on Metacritic’s best movies of all time list. The movie also has a 96% score on Rotten Tomatoes based on the first 56 reviews, with only two reviews considered “rotten,” or negative. The Associated Press hailed the movie as “an American masterpiece,” noting the movie touches on topical political themes and depicts a society where “gun violence, white power and immigrant deportations recur in an ongoing dance, both farcical and tragic.” The movie stars DiCaprio as an ex-revolutionary who reunites with former accomplices to rescue his 16-year-old daughter when she goes missing, and Anderson has said the movie was inspired by the 1990 novel, “Vineland.” Most critics have described the movie as an action thriller with notable chase scenes, which jumps in time from DiCaprio’s character’s early days with fictional revolutionary group, the French 75, to about 15 years later, when he is pursued by foe and military leader Captain Steven Lockjaw, played by Sean Penn. The Warner Bros.-produced film was made on a big budget, estimated to be between $130 million and $175 million, and co-stars Penn, Benicio del Toro, Regina Hall and Teyana Taylor. When Will ‘one Battle After Another’ Open In Theaters And Streaming? The move opens in…
Share
BitcoinEthereumNews2025/09/18 07:35
XRP Delivers Impressive ETF Volumes But Digitap ($TAP) is the King of Cross-Border Payments in 2026

XRP Delivers Impressive ETF Volumes But Digitap ($TAP) is the King of Cross-Border Payments in 2026

XRP has dominated crypto headlines recently. Spot XRP ETFs brought over $1 billion in institutional inflows, and total ETF-held assets now sit at $1.47 billion.
Share
Brave Newcoin2026/01/14 03:58
Strive Completes Acquisition of Bitcoin Treasury Firm Semler

Strive Completes Acquisition of Bitcoin Treasury Firm Semler

The post Strive Completes Acquisition of Bitcoin Treasury Firm Semler appeared on BitcoinEthereumNews.com. Strive Inc. (ASST) and Semler scientific (SMLR) were
Share
BitcoinEthereumNews2026/01/14 04:29